Gene Query: CSF2RB

Dataset Description Geneva Score
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 87.15
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 77.28
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 71.65
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 71.65
SRSF2 mutations impair hematopoiesis and alter exon recognition 55.73
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 52.64
Proliferation-correlated expression 52.43
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 51.19
Selective suppression of endothelial cytokine production by progesterone receptor 51.19
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 50.43
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 48.86
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 47.13
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 47.13
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 39.85
MEIS1 regulates hematopoiesis in hPSCs 38.6
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 38.52
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 37.48
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 37.05
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 36.7
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 36.17
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 33.27
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 32.83
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 32.44
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 32.4
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 31.46
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 31.42
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 31.38
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 30.17
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 29.52
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 29.19
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 29.06
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 28.98
Human neutrophil genome during PMA- and E. coli encounter-induced activation 28.59
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 28.59
Primary human trophoblast from term placenta 27.7
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 27.05
BACH2 in human plasma cell fate decision 26.6
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 25.01
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 24.21
Developmental stage specific chromosome architecture in human erythroid cells 24.21
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 23.68
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 23.68
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 23.64
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 23.62
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 23.62
Pharmacologic inhibition of STAT5 in AML 23.39
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 22.75
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 21.77
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 21.72
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 20.97
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 20.89
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 20.89
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 20.65
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 19.28
Be1 and Be2 B cells are transcriptionally distinct 19.01
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 18.93
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 18.76
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 18.73
CircRNAome diversity in human mature B-cells, T-cells and monocytes 18.71
mRNA expression profile of Lymphocytes 18.45
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 18.25
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 18.06
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 17.93
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 17.81
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 17.81
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 17.29
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 17.27
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 17.26
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 17.08
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 17.03
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 16.76
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 16.63
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 16.63
mRNA expression profile of Lymphocytes by high-throuput sequencing 16.51
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 16.41
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 16.41
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 16.26
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 15.96
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 15.75
Human cells contain natural double-stranded RNAs with potential regulatory capacity 15.68
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 15.52
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 15.31
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 15.09
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 15.07
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 15.03
Ro60-knockout cells 14.9
Statins modulate endothelial transcriptional profile by inhibiting EZH2 14.79
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 14.61
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 14.44
Transcriptional profiles of normal human mature B cells 14.34
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 14.27
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 14.16
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 14.14
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 14.14
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 14.13
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 13.83
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 13.79
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 13.79
The role of FAM46C in myeloma cells [sequencing] 13.63
The role of FAM46C in myeloma cells 13.63
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 13.11
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 13.11
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 12.96
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 12.83
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 12.83
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 12.68
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 12.68
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 12.6
Generation and functional characterization of MDSC-like cells 12.1
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 12.06
Irf9 function in immunity in mouse 12.02
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 12.02
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 12.02
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 11.96
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 11.96
Global response to chemotherapy-induced apoptosis 11.81
Effect of PRDM11 depletion in U2932 cells 11.78
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 11.68
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 11.59
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 11.43
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 11.41
miRNAs affected by antagomiR-17 treatment 11.36
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 11.26
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 11.26
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 11.19
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 11.1
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 11.06
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 10.78
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 10.68
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 10.49
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 10.27
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 10.19
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 10.19
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 10.13
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 10.07
Hepatosplenic T cell lymphoma 10.07
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 10.05
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 9.97
Anti-inflammatory effect of indoleacrylic acid (IA) 9.72
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 9.72
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 9.59
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 9.53
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 9.51
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 9.44
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 9.36
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 9.27
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 9.22
Gene expression profile of human placenta from T. Cruzi infected mothers 9.14
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 9.02
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.92
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.92
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 8.89
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 8.89
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 8.87
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 8.83
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 8.78
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 8.75
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 8.63
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 8.63
RNA-seq of stable and unstable section of human atherosclerotic plaques 8.5
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 8.31
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.3
Primary Human B-cell Temporal Response to CD40L Stimulation 8.17
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 8.12
A map of gene expression in neutrophil-like cell lines 8.1
Investigation about fibroblasts of different origins in culture 8.06
circRNA profile in hypopharyngeal cancer 8.05
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 8.04
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 8.0
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 7.91
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 7.83
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.83
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 7.83
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 7.83
Targeted enhancer activation by a subunit of the integrator complex 7.83
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 7.74
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 7.73
Transcriptomes of human monocytes after ex vivo exposure to uric acid 7.71
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 7.66
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 7.66
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 7.66
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 7.65
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 7.52
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 7.38
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 7.36
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 7.36
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 7.29
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 7.27
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.26
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 7.23
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 7.2
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.19
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 7.19
Widespread intronic polyadenylation diversifies immune cell transcriptomes 7.13
LncRNA expression profiling of ischemic stroke patients 7.09
Transcription control by the ENL YEATS domain in acute leukemia 7.03
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 7.03
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 7.02
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 6.98
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 6.97
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 6.97
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 6.82
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 6.81
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 6.78
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 6.72
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.72
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 6.67
MAIT cell RNA sequencing 6.58
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 6.53
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 6.47
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 6.41
A practical evaluation of alignment algorithms for RNA variant calling analysis 6.38
Microglia innatly develop within cerebral organoids 6.36
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 6.15
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 6.15
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 6.15
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 6.14
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 6.14
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 6.13
RNA-seq of Single-Cell Genotyping of Transcriptomes 6.13
Single-Cell Genotyping of Transcriptomes 6.13
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 6.07
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 6.01
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 6.0
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.0
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 6.0
Landscape and variation of RNA secondary structure across the human transcriptome 5.99
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 5.95
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 5.87
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.86
Intron retention induced by microsatellite expansions as a disease biomarker. 5.77
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 5.75
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.72
A Unique Epigenomic Landscape Defines Human Erythropoiesis 5.67
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 5.67
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.66
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 5.66
Short and Long RNA sequencing of human mature erythrocytes 5.6
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 5.58
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 5.56
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 5.56
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 5.55
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 5.55
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 5.52
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 5.52
A novel target of EZH1/2 for treatment of mantle cell lymphoma 5.48
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 5.37
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 5.36
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 5.35
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 5.29
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 5.29
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 5.29
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 5.24
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 5.2
The evolution of N6-methyladenosine in primates 5.12
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.1
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.1
A single cell reference map for human blood and tissue T cell activation 5.05
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 5.03
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 4.99
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 4.94
Efficient derivation of microglia-like cells from human pluripotent stem cells 4.94
ZIKV infection of monocytes activates inflammasome pathways 4.93
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 4.91
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.89
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 4.89
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 4.89
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 4.88
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 4.84
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 4.84
RNA-seq analysis of differentiating human erythroblasts 4.81
ML29755 RNA-seq data 4.8
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.8
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.78
Expression analysis of the TAF1 syndrome 4.76
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 4.75
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 4.72
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 4.72
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 4.72
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 4.68
NAPRT activation of macrophages 4.67
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 4.66
Reprogrammed myeloid cell transcriptomes in NSCLC 4.65
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 4.58
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 4.58
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 4.55
Exploring the RNA landscape of endothelial exosomes 4.5
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 4.48
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.46
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 4.45
Transcriptional profile in human S. haematobium infection 4.41
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 4.23
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 4.23
Polarized B -cell functions 4.14
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 4.14
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 4.14
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.11
Loss of CREBBP results in gene expression repression in lymphoma cells 4.11
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.11
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.09
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 4.01
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 4.0
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.0
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.99
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.99
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.97
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.97
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 3.97
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 3.91
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 3.91
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 3.87
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 3.85
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 3.85
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 3.84
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.74
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.7
RNA-sequencing of human tendon after injury 3.69
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 3.63
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 3.63
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 3.63
Global analysis of alternative splicing regulated by RBM10 3.62
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.61
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 3.55
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 3.55
Macrophage Ad5f35 PhenoMap 3.5
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 3.48
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.38
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.38
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.37
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 3.36
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 3.36
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 3.34
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.32
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 3.32
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 3.29
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.28
Leucegene: AML sequencing (part 6) 3.24
Differences in miRNA Detection Levels are Technology and Sequence Dependent 3.21
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 3.21
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.14
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.06
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 3.03
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.99
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.97
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.94
Bone marrow derived human B cells [normal proB] 2.94
Leucegene: ALL sequencing 2.93
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.83
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.83
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 2.82
Common inflammatory pathways between NEC and Crohn's disease 2.77
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.77
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.74
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.73
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 2.72
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.72
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 2.71
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.62
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 2.59
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.58
Landscape of H3K4me3 in human CD19 cells 2.56
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.56
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 2.55
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.54
CD86 regulates a pro-survival signal in myeloma cells 2.54
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.53
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.47
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.38
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.38
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 2.38
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.34
RNA-Seq and expression data from human adipose tissue 2.32
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.32
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 2.27
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.23
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.22
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.22
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.22
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 2.2
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 2.18
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.17
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 2.17
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.12
RNA-seq in endometrial stromal tumors 2.12
The landscape of alternative splicing in aggressive prostate cancers 2.0
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.97
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.96
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.94
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.92
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.88
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.87
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.83
Transcriptome analysis of peripheral blood monocytes 1.8
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.77
Aging-associated patterns in the expression of human endogenous retroviruses 1.77
Transcriptomic analysis of frontal fibrosing alopecia 1.74
Gene expression profile of multiple myeloma cell lines treated with CB-5083 1.71
Transcriptomic profiling of human peripheral blood-derived mast cells 1.71
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.71
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.71
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.71
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.7
Macrophage Ad5f35 M2 Challenge 1.69
Human ovarian granulosa cell transcriptome 1.66
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.6
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.59
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.58
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.58
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.57
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.57
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.55
Copper Regulation of HIF-1 Transcription Activity 1.55
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.55
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.53
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.53
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 1.51
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.5
Role of cervicovaginal microbiota in genital inflammation 1.49
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.46
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.46
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.44
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.42
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.39
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.37
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.37
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.36
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.34
Non-coding regions are the main source of tumor-specific antigens [human] 1.32
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.26
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.24
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.24
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.15
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.13
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.07
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 1.03
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.02
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.01
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 0.98
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.97
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.96
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.94
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.92
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.89
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.86
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 0.85
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 0.84
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.83
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 0.82
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.82
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.81
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.79
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.73
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.69
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.68
The Genetic Landscape of Diamond-Blackfan Anemia 0.67
RNA-seq of primary patient AML samples 0.65
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.63
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.6
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.58
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.53
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.46
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.46
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.46
Expression patterns in chronic thromboembolic pulmonary hypertension 0.45
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.44
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.44
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.43
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.42
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.41
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.39
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.39
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.39
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.36
Deep RNA sequencing of the human placental transcriptome 0.36
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.34
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.34
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.31
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.25
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.23
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.23
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.19
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.18
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.15
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.13
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.13
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.11
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.08
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.08
Specific molecular signatures underlie response to decitabine in CMML 0.08
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.07
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.04
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.04
Transcriptomic analysis of human macrophages in 3D 0.04
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.03
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.03
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.01
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.01
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.01
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.01
Impact on erythroid progenitor type on erythroid differntiation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation